Leeds Biomedical Research Centre (BRC) has launched with £20.4m funding to expand its portfolio of medical research. This will significantly strengthen the centre’s mandate for improving care for patients, with new research into numerous medical conditions.
Having previously operated with a sole research ‘theme’ of Musculoskeletal Disease, Leeds BRC has now expanded to six themes including: Antimicrobial Resistance and Infection, Cardiometabolic Disease, Haematology, Pathology and Surgical Technologies.
The BRC is part of a national network of centres funded by the National Institute for Health and Care Research (NIHR), aimed at uniting local academia and NHS resources to transform research into real world treatment improving patient outcomes.
The event to mark the launch was held in Leeds with a virtual ribbon cutting ceremony by representatives of the BRC’s partners from Leeds Teaching Hospitals NHS Trust (LTHT), the University of Leeds and the University of York.
Director of the BRC, Professor Philip Conaghan said: “our new £20M multi-themed NIHR Leeds BRC brings together existing excellence in clinical research across Leeds Teaching Hospitals NHS Trust and the University of Leeds to address multiple long-term conditions and we are especially delighted to have brought the University of York into the NIHR Leeds BRC partnership and look forward to extending this collaboration in the coming years.
Our patient informed research will deliver important early translational results to improve the health and wealth of our communities as well as enabling us a strengthened opportunity to develop the clinical research workforce of the future”.
Presentations from the Event
Welcome and Introduction – Prof Philip Conaghan
Surgical Technologies – Prof David Jayne
Pathology – Prof Philip Quirke
Antimicrobial Resistance – Prof Mark Wilcox
Musculoskeletal Disease – Prof Ann Morgan
Haematology – Dr Darren Newton